GenHealth.ai
Markets
Use Cases
Products
Company
Docs
Get a Demo
Automated Prior Authorization
with Generative AI. See how we support health plans and providers with prior auth.
Generative AI Healthcare Analytics
Use natural language to ask any question of your data: past, present, and future.
Search all medical codes
Z11.4
Encounter for screening for human immunodeficiency virus [HIV]
ICD10CM code
Medical Policies and Guidelines for Encounter for screening for human immunodeficiency virus [HIV]
Related policies from health plans
OSCAR
Apretude (cabotegravir extended-release injectable suspension) (PG158)
OSCAR
Apretude (cabotegravir extended-release injectable suspension) (PG158)
CIGNA
Nucleic Acid Pathogen Testing - (0530)
CIGNA
Nucleic Acid Pathogen Testing - (0530)
CIGNA
Nucleic Acid Pathogen Testing - (0530)
CIGNA
Nucleic Acid Pathogen Testing - (0530)
CIGNA
Nucleic Acid Pathogen Testing - (0530)
CIGNA
Nucleic Acid Pathogen Testing - (0530)
CIGNA
Nucleic Acid Pathogen Testing - (0530)
CIGNA
Nucleic Acid Pathogen Testing - (0530)
CIGNA
Nucleic Acid Pathogen Testing - (0530)
CIGNA
Preventive Care Services - (A004)
CIGNA
Transvaginal Ultrasound, Non-Obstetrical - (0398)
Similar Codes
ICD10CM codes
Z11.4
- Encounter for screening for human immunodeficiency virus [HIV]
Z20.6
- Contact with and (suspected) exposure to human immunodeficiency virus [HIV]
Z83.0
- Family history of human immunodeficiency virus [HIV] disease
Z11.5
- Encounter for screening for other viral diseases
B20
- Human immunodeficiency virus [HIV] disease
Z11.3
- Encounter for screening for infections with a predominantly sexual mode of transmission
Z71.7
- Human immunodeficiency virus [HIV] counseling
Z11.52
- Encounter for screening for COVID-19
Z11.59
- Encounter for screening for other viral diseases
Z11.51
- Encounter for screening for human papillomavirus (HPV)
HCPCS codes
G0432
- Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, scree
G0433
- Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 an
G0435
- Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening
G0475
- Hiv antigen/antibody, combination assay, screening
T1023
- Screening to determine the appropriateness of consideration of an individual for participation in a
D0190
- Screening of a patient
G0472
- Hepatitis c antibody screening, for individual at high risk and other covered indication(s)
J3485
- Injection, zidovudine, 10 mg
G9228
- Chlamydia, gonorrhea and syphilis screening results documented (report when results are present for
G0431
- Drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, e
CPT4 codes
4293F
- Patient screened for high-risk sexual behavior (HIV)
3511F
- Chlamydia and gonorrhea screenings documented as performed (HIV)
3510F
- Documentation that tuberculosis (TB) screening test performed and results interpreted (HIV) (IBD)
86702
- Antibody; HIV-2
87390
- Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-l
87806
- Infectious agent antigen detection by immunoassay with direct optical observation; HIV-1 antigen(s),
86701
- Antibody; HIV-1
86689
- Antibody; HTLV or HIV antibody, confirmatory test (eg, Western Blot)
87539
- Infectious agent detection by nucleic acid (DNA or RNA); HIV-2, quantification, includes reverse tra
87536
- Infectious agent detection by nucleic acid (DNA or RNA); HIV-1, quantification, includes reverse tra